These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9875686)

  • 1. Study of the pharmacokinetics of cefpirome sulphate in the elderly.
    Sugihara H; Narita N; Takatsu R; Horiuchi M; Yonenami K; Hotta M; Shibahara K; Kamo T; Negishi Y
    J Clin Pharm Ther; 1998 Oct; 23(5):375-9. PubMed ID: 9875686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.
    Lipman J; Wallis SC; Rickard CM; Fraenkel D
    Intensive Care Med; 2001 Feb; 27(2):363-70. PubMed ID: 11396280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
    Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
    Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and multiple-dose pharmacokinetics of intravenous cefpirome (HR810) to healthy volunteers.
    Nakayama I; Akieda Y; Yamaji E; Nitta Y; Ohishi M; Katagiri K; Imamura N; Takase K
    J Clin Pharmacol; 1992 Mar; 32(3):256-66. PubMed ID: 1564130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime versus cefpirome: the importance of creatinine clearance.
    Lipman J; Wallis SC; Boots RJ
    Anesth Analg; 2003 Oct; 97(4):1149-1154. PubMed ID: 14500173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
    Roos JF; Lipman J; Kirkpatrick CMJ
    Intensive Care Med; 2007 May; 33(5):781-788. PubMed ID: 17342515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory and clinical studies of cefpirome in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1991 Apr; 44(4):454-61. PubMed ID: 1880924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerance and pharmacokinetics of 2.0 g cefpirome (HR 810) after single and multiple dosing.
    Badian M; Malerczyk V; Collins JD; Dixon GT; Verho M; Eckert HG
    Chemotherapy; 1988; 34(5):367-73. PubMed ID: 3180904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerance and pharmacokinetics of cefpirome administered intramuscularly to healthy subjects.
    Meyer BH; Muller FO; Luus HG; Drees B; Röthig HJ; Badian M; Eckert HG
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():63-70. PubMed ID: 1601759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection.
    Wilcox MH; Pithie A; Smith G; Moreland TA; Davey PG; Finch RG
    J Antimicrob Chemother; 1991 Aug; 28(2):291-9. PubMed ID: 1778859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration.
    Van der Werf TS; Fijen JW; Van de Merbel NC; Spanjersberg R; Möller AV; Ligtenberg JJ; Tulleken JE; Zijlstra JG; Stegeman CA
    Intensive Care Med; 1999 Dec; 25(12):1427-31. PubMed ID: 10660852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs.
    Isert D; Klesel N; Limbert M; Markus A; Seibert G; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():31-7. PubMed ID: 1601754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and clinical studies on flomoxef in neonates and premature infants. A study of flomoxef in the perinatal collaboration research group].
    Fujii R; Fujita K; Murono K; Saijo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
    Jpn J Antibiot; 1993 Jul; 46(7):518-38. PubMed ID: 8371489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of cefpirome into sputum in chronic respiratory infections: comparison of administration of 0.5 g and 1.0 g in the same patient.
    Shishido H; Nagai H; Miyake S; Kaburagi T; Satoh K; Deguchi K
    Int J Clin Pharmacol Res; 1993; 13(4):225-9. PubMed ID: 8150549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus.
    Sauermann R; Feurstein T; Karch R; Kjellsson MC; Jäger W; Böhmdorfer M; Püspök A; Langenberger H; Wild T; Winkler S; Zeitlinger M
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1419-23. PubMed ID: 22441316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.
    Rajput N; Dumka VK; Sandhu HS
    J Vet Sci; 2007 Mar; 8(1):21-5. PubMed ID: 17322770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis.
    Joukhadar C; Klein N; Mayer BX; Kreischitz N; Delle-Karth G; Palkovits P; Heinz G; Müller M
    Crit Care Med; 2002 Jul; 30(7):1478-82. PubMed ID: 12130965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.
    Kavi J; Andrews JM; Ashby JP; Hillman G; Wise R
    J Antimicrob Chemother; 1988 Dec; 22(6):911-6. PubMed ID: 3243739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal penetration of cefpirome.
    Kavi J; Ashby JP; Wise R; Donovan IA
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):556-8. PubMed ID: 2504599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.